Weight Loss Program in Patients with Atherosclerosis: A randomised Controlled Clinical Trial
Keywords:
atherosclerosis, fatty overweight, low-calorie, fat-free diet, weight loss therapy
Abstract
Atherosclerosis(AS) is one of the most common disease sleading tosevere clinical complications. Atherosclerosis forms pockets of fat and lipid deposit sunder the mucous tunic of blood vessels, which cause progressive vasoconstriction until total luminal blockage occurs. 1 Many "Civilization diseases" such as coronary artery disease (CAD), arterial hypertension (AH), diabetes mellitus (DM), psoriasis, gout, and such conditions as hyper lipidemia, hyperglycemia, dyslipidemia, hyperinsulinemia, hypercortisolemia, hyperuricemia, and microalbuminuria are connected with AS development. In these regards, the problem of developing a proven clinical solution for this prevalent disease process is a socially significant one.1,2 During the last 20 years, ASmorbidity has been globally increasing.2,3 Mortality from AS complications, which account for 75-85% of general mortalityinwhole,4 is simultaneously increasing.Thus AS is one of the global problems of conventional medicine.
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
References
The Emerging Risk Factors Collaboration* (2009) Major Lipids, Apolipoproteins, and Risk of Vascular Disease. 302, 1993.
Y. Nesterov (2007) Nesterov Y. Atherosclerosis: diagnosis, treatment, prophylaxis: guide for physicians in primary care of Public Health. Medicine: Phoenix. 2007, 254.
De Oliveira, Omc Mozaffarian, D. Kromhout, D. (2012) Dietary intake of saturated fat by food source and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis AmJ Clin Nutr. 96(2), 397-404.
Bjorge T (2008) Body mass index in adolescence in relation to cause-specific mortality: a follow-up of 230,000 Norwegian adolescents. 168(1), 30-7.
Cao JJ (2007) Association of carotid artery intimamedia thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. 116(1), 32-38.
Xianqing Mao, Karima Ait-Aissa, Jeremy Lagrange, Gina Youcef, Huguette Louis (2012) Hypertension, hypercoagulability and the metabolic syndrome: A cluster of risk factors for cardiovascular disease. 22(1-3), 35-48. https://doi.org/10.3233/bme-2012-0688
Sung KC, Wild SH, Kwan HJ, Byrne CD (2012) Fatty Liver, Insulin Resistance, and Features of Metabolic Syndrome: Relationships with coronary artery calcium in 10,153 people.
Bal SS, Khurana D, Sharma A, Lal V, Bhansali A, Prabhakar S (2011) Association of metabolic syndrome with carotid atherosclerosis in the young North Indian population. 5(3), 153-7.
P. Zimmet, G. Alberti, J. Shaw (2005) A New worldwide definition of the metabolic syndrome: the rationale and the results. 3(50), 31-33.
R. Reitano, G. Urso, F. Barbagallo, V. Giustolisi (1985) Reitano R, Urso G, Barbagallo F, Giustolisi V. Cerebral hypoxia as a pathogenetic component in the acute exacerbation of hepatic cirrhosis encephalopathy. 76(7-8), 424.
OshakbayevKP (2007) Clinical management of metabolic syndrome. 2, 32.
K. Oshakbayev (2007) Invention patent of the Republic of Kazakhstan, #13868 from 16.07.2007.
Abylayulyzh OshakbayevKP (2006) an alimentary detoxification.
Oshakbayev KP, Izatullayev EA, Boborykin VM (2011) The nonmedical treatment method of atherosclerosis.
S. Lapach, A. Chubenko, P. Babich (2000) Statistical methods in medical and biologic researches with use Excel. 319.
Lemieux S, Despres JP, Moorjani S, Nadeau A, Theriault G (1994) Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue?. 37(8), 757-764. https://doi.org/10.1007/bf00404332
A. Blann (2000) Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms? Blood Coagul Fibrinolysis. 11(7), 623-630. https://doi.org/10.1097/00001721-200010000-00006
Houssen ME, Haron MM, Metwally SS, Ibrahim TM (2011) Effects of immunomodulatory drugs on plasma inflammatory markers in a rabbit model of atherosclerosis. 67(1), 115-120.
Viviane Rocha, Peter Libby (2009) Obesity,inflammation, and atherosclerosis Nat Rev Cardiol. 6(6), 399-409. https://doi.org/10.1038/nrcardio.2009.55
Hoi Y, Zhou YQ, Zhang X, Henkelman RM, Steinman DA (2011) Correlation between local hemo dynamics and lesion distributions in a novel aortic regurgitation murine model ofatherosclerosis. 39(5), 1414-22.
Xianqing Mao, Karima Ait-Aissa, Jeremy Lagrange, Gina Youcef, Huguette Louis (2012) Hypertension, hypercoagulability and the metabolic syndrome: A cluster of risk factors for cardiovascular disease Biomed Mater Eng. 22(1-3), 35-48. https://doi.org/10.3233/bme-2012-0688
(2012) American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis Endocr Pract. 1, 1-78.
Brott TG, Halperin JL, Abbara S, Bacharach JM (2011) Brott TG, Halperin JL, Abbara S, Bacharach JM. 124(4), 54-130.
C. Mihalcea, G. Pandele (2010) Correlation between atherosclerosis - coronary disease and insulin resistance, regarded as the basis of metabolic syndrome Rev Med ChirSoc Med Nat Iasi. 114(1), 59-68.
Ma Y, Wang W, Zhang J, Lu Y (2012) Hyperlipidemia and atherosclerotic lesion development in Ldlrdeficient mice on a long-term high-fat diet. 7(4), e35835. https://doi.org/10.1371/journal.pone.0035835
Bal SS, Khurana D, Sharma A, Lal V, Bhansali A, Prabhakar S (2011) Association of metabolic syndrome with carotidatherosclerosisin theyoung North Indian population. 5(3), 153-7.
K. Oshakbayev (2010) The role overweight in atherosclerosis development Almaty, 2010. 343.
Oshakbayev KP, Izatullayev EA, Boborykin VM, Dukenbayeva BA (2009) The conception of atherosclerosis evolution development in ontogenesis.
Cruz-Teno C, Pérez-Martínez P, Delgado-Lista J (2012) Dietary fat modifies the postprandial inflammatory state in subjects with metabolic syndrome: the LIPGENE study. 56(6), 854-65.
Pang J, Chan DC, Barrett PH, Watts GF (2012) Postprandial dyslipidaemia and diabetes: mechanistic and the rapeutic aspects. 23(4), 303-9.
Meneses ME, Camargo A, Perez-Martinez P, Delgado-Lista J (2011) Post prandialinflammatory response in adipose tissue of patients with metabolic syndrome after the intake of different dietary models. 55(12), 1759-70.
Sahade V, França S, Badaró R, Fernando L (2012) Obesity and postprandial lipemia in adolescents: risk factors for cardiovascular disease. 59(2), 131-9.
Ahmadi N, Eshaghian S, Huizenga R, Sosnin K (2011) Effects of intense exercise and moderate caloric restriction on cardiovascular risk factors and inflammation. 124(10), 978-82.
Mantyselka P, Kautiainen H, Saltevo J, Würtz P (2012) Weight change and lipoprotein particle concentration and particle size: a cohort study with 6.5-year follow-up Atherosclerosis. 223(1), 239-243.
Bradshaw PT, Monda KL, Stevens J (2012) Metabolic syndrome in healthy obese, overweight and normal weight individuals: the atherosclerosis risk in communities study. https://doi.org/10.1038/oby.2012.173
Abdulrahman Musaiger, Hazzaa Al-Hazzaa (2012) Prevalence and risk factors associated with nutrition-related non communicable diseases in the Eastern Mediterranean region Int J Gen Med. 5, 199.
Tavora F, Zhang Y, Zhang M, Li L, Ripple M, Fowler D, Burke A (2012) Cardiomegaly is a common arrhythmogenic substrate in adult sudden cardiac deaths, and is associated with obesity. 44(3), 187-91.
OshakbayevKP (2009) OshakbayevKP. Chemical discretion of organism lipids. 3, 315-316. http://www.ncvb.isd.kz/ru/vestnik.html
OshakbayevKP, Kurmankulov EspenbetovАA, Dukenbayeva Boborykin VM (2011) Chemical elemental analysis of different lipids of organism. 2, 23-27.
OshakbayevKP, B. Dukenbayeva, G. Tulepbergenova (2010) Impact of fatty overweight on several biological and physical parameters in patients with atherosclerosis. 8, 5-14.
OshakbayevKP, A. Nersesov, B. Dukenbayeva (2010) The conception of aging of sorption function of erythrocytes at metabolic syndrome. 2, 17-23.
OshakbayevKP (2009) Atherosclerotic plaque is a highenergy lipid. - In book of materials of International practical and scientific Congress. 4, 125-126.
OshakbayevKP (2011) Atherosclerosis is the result of metabolic aging of lipids. 1, 89-102.
Idrisov OshakbayevKP, AS, BegaliyevShS, A. Narynbayev, B. Dukenbayeva (2009) Insulinresistance at metabolic syndrome: development mechanism Vestnic med. 3(32), 97-107.
OshakbayevKP, R. Areshov, B. Dukenbayeva Development conception of blood pressure at metabolic syndrome. http://7rm.ru/
Koehlmoos TP, Anwar S, Cravioto A (2011) Global health: chronic diseases and other emergent issues in global health. 25(3), 623-38.
Kadota A, Miura K, Okamura T, Hozawa A, Murakami Y (2011) NIPPON DATA90 Research Group Relationship of moderate metabolic risk factor clustering to cardiovascular disease mortality in non-lean Japanese: a 15-year follow-up of NIPPON DATA90 Atherosclerosis. 215(1), 209-213.
(2011) WHO maps non communicable disease trends in all countries: country profiles on non-communicable disease trends in 193 countries. 19(3), 130-138.
Published
2013-01-25
Issue
Section
License
Copyright (c) 2013 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.